| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | -0.14 | 0.0002 |
| mRNA | Tipifarnib | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0004 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |